200 10510 cohort:1.16101785485554 design:2.29943659920322 draw:1.80971327284465 eric:4.53974238066564 figure:1.80971327284465 follow:1.02323415249249 gonna:3.55891312765391 health:1.34789522818535 lorelei:4.53974238066564 mucci:4.25206030821386 professionals:3.44113009199753 researchers:1.94947521521981 rimm:4.53974238066564 study:1.18408166947574 talk:0.84683782344952 thought:1.92478260262944
10510 19410 case:0.325148690291958 cohort:2.32203570971108 control:0.919855798038651 design:1.14971829960161 draw:1.80971327284465 eric:4.53974238066564 figure:1.80971327284465 follow:1.02323415249249 health:1.34789522818535 levels:1.07400647786591 nested:2.93030446823154 professionals:3.44113009199753 researchers:3.89895043043962 rimm:4.53974238066564 risk:0.614474148487469 selenium:3.84659520010569 study:1.48010208684467 talked:0.42341891172476 thought:1.92478260262944 undertook:4.53974238066564
19410 29640 advanced:3.55891312765391 cancer:1.54401010711165 case:0.325148690291958 cohort:2.32203570971108 control:0.919855798038651 design:1.14971829960161 eric:4.53974238066564 follow:2.04646830498498 health:2.6957904563707 levels:1.07400647786591 nested:2.93030446823154 professionals:6.88226018399506 prostate:3.84659520010569 remember:0.417998844255421 researchers:1.94947521521981 rimm:4.53974238066564 risk:0.614474148487469 selenium:3.84659520010569 started:0.748005541111992 study:1.48010208684467 talked:0.42341891172476 undertook:4.53974238066564
29640 36700 advanced:3.55891312765391 cancer:3.0880202142233 case:0.325148690291958 cohort:1.16101785485554 control:0.919855798038651 men:2.38025813131226 follow:1.02323415249249 men:2.38025813131226 health:1.34789522818535 questionnaire:2.27105883934727 50000:3.84659520010569 levels:1.07400647786591 1986:2.72337710063538 nested:2.93030446823154 professionals:3.44113009199753 prostate:3.84659520010569 invited:2.74798291143758 remember:0.417998844255421 researchers:1.94947521521981 risk:0.614474148487469 selenium:3.84659520010569 started:0.748005541111992 study:0.888061252106805 undertook:4.53974238066564
36700 47020 advanced:3.55891312765391 cancer:4.63203032133495 men:2.38025813131226 follow:1.02323415249249 men:2.38025813131226 health:1.34789522818535 free:1.44869992730732 questionnaire:2.27105883934727 50000:3.84659520010569 1986:2.72337710063538 professionals:3.44113009199753 prostate:7.69319040021138 invited:2.74798291143758 remember:0.417998844255421 started:0.748005541111992 study:0.296020417368935
47020 57210 initially:3.0880202142233 investigators:1.68711095075232 men:2.38025813131226 follow:1.02323415249249 men:2.38025813131226 health:1.34789522818535 free:1.44869992730732 questionnaire:2.27105883934727 year:0.675510039073838 started:1.66806275578162 50000:3.84659520010569 1986:4.08506565095307 professionals:3.44113009199753 cancer:3.84659520010569 invited:2.74798291143758 remember:0.417998844255421 started:1.49601108222398 study:0.59204083473787 study:1.92478260262944 thought:4.02891675689965 men:0.485063074835967
57210 69030 source:3.55891312765391 cancer:1.54401010711165 interesting:1.68711095075232 takes:1.94947521521981 including:1.44869992730732 thought:0.675510039073838 year:1.66806275578162 50000:1.36168855031769 study:4.25206030821386 prostate:3.84659520010569 toenails:0.834333624600489 toenails:2.54731221597543 men:0.748005541111992 started:0.59204083473787 nail:0.859231176222216 investigators:1.92478260262944 collect:8.0578335137993 study:0.970126149671934
69030 77130 beginning:1.51122028428865 biological:3.24045939653538 biomarkers:3.55891312765391 clipping:4.02891675689965 collect:1.68711095075232 end:0.802072762382268 entire:1.94947521521981 grow:3.15344801954575 interesting:0.675510039073838 levels:1.07400647786591 nail:8.50412061642772 part:1.0844777777332 reason:0.834333624600489 source:2.54731221597543 study:0.59204083473787 takes:1.71846235244443 toenails:8.0578335137993 year:0.485063074835967
77130 87530 beginning:1.51122028428865 biological:3.24045939653538 biomarkers:3.55891312765391 clipping:4.02891675689965 end:0.802072762382268 entire:1.94947521521981 factors:0.90215622093925 grow:3.15344801954575 happened:0.60791674794131 levels:1.07400647786591 50000:1.36168855031769 nail:8.50412061642772 part:1.0844777777332 previous:0.867670044868081 reflect:1.49521994294221 specimens:3.69244452027843 study:0.59204083473787 takes:1.71846235244443 toenail:4.02891675689965 year:0.970126149671934
87530 97430 beginning:1.51122028428865 biological:3.24045939653538 clipping:4.02891675689965 end:0.802072762382268 factors:0.90215622093925 health:1.02323415249249 grow:3.15344801954575 happened:0.60791674794131 37000:1.34789522818535 levels:1.07400647786591 toenails:2.74798291143758 50000:1.36168855031769 nail:4.25206030821386 part:1.0844777777332 previous:0.867670044868081 man:3.44113009199753 reflect:1.49521994294221 specimens:3.69244452027843 study:0.59204083473787 taking:0.859231176222216 toenail:8.0578335137993 year:0.485063074835967
97430 105590 population:0.325148690291958 nested:0.919855798038651 factors:0.90215622093925 health:1.02323415249249 happened:0.60791674794131 37000:1.34789522818535 toenails:2.74798291143758 50000:1.36168855031769 source:2.93030446823154 study:0.514390689930487 previous:0.867670044868081 man:3.44113009199753 reflect:1.49521994294221 follow:2.54731221597543 specimens:3.69244452027843 professionals:0.59204083473787 toenail:8.0578335137993 year:0.485063074835967
105590 114280 ed:3.24045939653538 study:0.244727122981384 nested:0.325148690291958 case:0.919855798038651 study:4.9452074887738 professionals:1.02323415249249 1987:4.9452074887738 man:1.34789522818535 author:1.26890681686672 37000:2.74798291143758 population:2.93030446823154 source:0.514390689930487 health:3.44113009199753 study:2.54731221597543 follow:0.888061252106805 toenails:4.02891675689965
114280 122890 giovannucci:3.24045939653538 hypothesis:0.244727122981384 case:0.325148690291958 hypothesis:7.69319040021138 control:0.919855798038651 1987:4.9452074887738 ed:4.9452074887738 study:2.53781363373344 1987:9.8904149775476 nested:2.93030446823154 population:0.514390689930487 study:1.17244655067916 clark:1.38985942728439 source:2.54731221597543 study:1.18408166947574 referred:1.54401010711165
122890 132510 author:3.24045939653538 back:0.244727122981384 larry:7.69319040021138 ed:9.8904149775476 giovannucci:4.9452074887738 hypothesis:3.80672045060016 hypothesis:9.8904149775476 trial:2.38025813131226 referred:1.17244655067916 study:1.38985942728439 study:1.18408166947574 randomized:1.54401010711165
132510 139200 study:0.244727122981384 clark:7.69319040021138 hypothesis:1.68711095075232 1996:4.9452074887738 hypothesis:2.53781363373344 larry:9.8904149775476 stored:0.396607654274103 published:2.38025813131226 randomized:1.17244655067916 referred:1.38985942728439 wanted:3.84659520010569 collection:2.99929733971849 study:0.888061252106805 back:8.0578335137993 trial:1.54401010711165 toenails:0.956223442209526
139200 147090 study:0.244727122981384 hypothesis:1.68711095075232 1996:4.9452074887738 toenails:3.84659520010569 1996:1.26890681686672 selenium:1.66806275578162 stored:0.396607654274103 published:2.38025813131226 wanted:3.84659520010569 collection:2.99929733971849 ed:0.59204083473787 back:8.0578335137993 toenails:0.956223442209526
147090 156820 hypothesis:0.244727122981384 back:1.68711095075232 ed:4.9452074887738 limited:3.84659520010569 study:1.26890681686672 selenium:1.07400647786591 toenails:1.66806275578162 wanted:0.793215308548206 levels:1.36168855031769 measure:7.69319040021138 toenails:2.99929733971849 1996:0.59204083473787 collection:8.0578335137993 stored:0.956223442209526
156820 165550 nested:0.325148690291958 case:0.919855798038651 study:4.9452074887738 ed:0.802072762382268 1996:1.02323415249249 funds:3.84659520010569 levels:1.07400647786591 limited:1.66806275578162 measure:0.793215308548206 37000:1.36168855031769 undertook:2.93030446823154 selenium:7.69319040021138 stored:2.99929733971849 study:0.888061252106805 toenails:4.02891675689965 men:4.53974238066564 wanted:0.956223442209526
165550 174130 study:3.55891312765391 follow:1.28164584264415 basically:1.54401010711165 nested:0.650297380583916 case:0.919855798038651 study:4.9452074887738 ed:0.802072762382268 1996:1.02323415249249 37000:1.36168855031769 undertook:2.93030446823154 prostate:1.57791165878733 1994:3.84659520010569 control:0.59204083473787 men:4.53974238066564
174130 183460 1994:7.11782625530782 study:1.28164584264415 advanced:3.0880202142233 prostate:0.650297380583916 ed:4.9452074887738 1996:0.802072762382268 ended:1.02323415249249 cancer:1.57791165878733 undertook:1.78820706762369 basically:7.69319040021138 prostate:0.614474148487469 cases:0.668541369757745 risk:1.44869992730732 cancer:0.37566448042886 follow:0.296020417368935 advanced:4.53974238066564
183460 195230 advanced:7.11782625530782 basically:1.28164584264415 cancer:3.0880202142233 cases:0.975446070875874 order:0.919855798038651 set:1.83169217956343 risk:0.526366880977203 occurred:1.57791165878733 set:1.78820706762369 prostate:7.69319040021138 controls:0.417998844255421 cases:1.22894829697494 risk:0.668541369757745 sampling:1.44869992730732 undertook:0.75132896085772 select:0.296020417368935 cancer:4.53974238066564
195230 203070 advanced:3.55891312765391 cancer:3.0880202142233 cases:0.650297380583916 controls:0.919855798038651 risk:0.87618073453599 identified:1.83169217956343 1988:0.810040932031445 means:0.526366880977203 looked:1.36168855031769 number:0.153557735843091 order:1.78820706762369 prostate:7.69319040021138 remember:0.417998844255421 risk:1.84342244546241 sampling:0.668541369757745 select:1.44869992730732 set:0.75132896085772 study:0.296020417368935 cancer:0.0700101655726489 undertook:4.53974238066564
203070 212740 prostate:1.54401010711165 case:0.650297380583916 controls:2.75956739411595 risk:0.87618073453599 identified:1.83169217956343 1988:0.810040932031445 means:0.526366880977203 looked:1.36168855031769 control:2.93030446823154 number:0.153557735843091 developing:3.84659520010569 remember:0.417998844255421 risk:1.84342244546241 set:0.668541369757745 time:1.44869992730732 set:0.75132896085772 study:0.59204083473787 cancer:0.0700101655726489
212740 223500 prostate:1.54401010711165 nested:0.325148690291958 selected:1.8397115960773 risk:0.87618073453599 specimen:0.778542264972074 health:1.02323415249249 37000:1.34789522818535 1988:0.810040932031445 looked:2.72337710063538 control:5.86060893646308 number:0.153557735843091 men:3.44113009199753 developing:3.84659520010569 toenail:1.94947521521981 men:1.22894829697494 set:0.668541369757745 time:1.44869992730732 risk:0.37566448042886 study:3.69244452027843 control:0.59204083473787 cancer:0.0700101655726489 follow:4.02891675689965
223500 236090 skin:1.54401010711165 case:0.325148690291958 larry:3.84659520010569 find:0.634408363388287 control:0.919855798038651 results:2.41947884446554 researchers:0.778542264972074 professionals:1.02323415249249 study:1.76715365842585 men:1.34789522818535 found:4.9452074887738 men:4.53974238066564 37000:2.72337710063538 nested:5.86060893646308 health:3.44113009199753 clark:1.17244655067916 specimen:1.94947521521981 compare:0.634408363388287 risk:0.614474148487469 sampling:0.668541369757745 set:0.37566448042886 melanoma:3.69244452027843 toenail:3.69244452027843 study:0.888061252106805 study:4.02891675689965 randomized:1.54401010711165
236090 247620 cancer:1.54401010711165 clark:3.84659520010569 compare:0.634408363388287 epidemiological:2.41947884446554 find:0.778542264972074 found:1.76715365842585 health:1.34789522818535 larry:4.9452074887738 selenium:1.07400647786591 toenails:0.396607654274103 melanoma:4.53974238066564 men:2.72337710063538 population:0.514390689930487 professionals:3.44113009199753 randomized:1.17244655067916 researchers:1.94947521521981 results:0.634408363388287 measured:3.84659520010569 skin:3.69244452027843 source:2.54731221597543 study:0.59204083473787 men:8.0578335137993 trial:1.54401010711165
247620 257190 develop:3.55891312765391 cancer:3.0880202142233 follow:0.325148690291958 men:0.87618073453599 years:2.04646830498498 health:1.34789522818535 selenium:1.07400647786591 toenails:0.396607654274103 melanoma:4.53974238066564 33000:2.72337710063538 follow:0.153557735843091 population:0.514390689930487 professionals:3.44113009199753 advanced:3.84659520010569 measured:3.84659520010569 skin:3.69244452027843 source:2.54731221597543 study:0.296020417368935 men:8.0578335137993 toenails:0.970126149671934
257190 267320 advanced:3.55891312765391 calculate:0.550758334101362 cancer:1.54401010711165 cases:0.325148690291958 controls:0.919855798038651 develop:0.87618073453599 follow:2.04646830498498 found:1.76715365842585 highest:3.15344801954575 levels:2.14801295573182 measured:0.793215308548206 men:2.72337710063538 number:0.153557735843091 odds:0.984394319176222 prostate:3.84659520010569 ratios:0.654748047625409 relative:2.34251780332942 risk:0.614474148487469 selenium:7.69319040021138 toenails:4.02891675689965 years:0.970126149671934
267320 274870 developing:3.55891312765391 calculate:0.550758334101362 prostate:1.54401010711165 cancer:0.634408363388287 controls:0.919855798038651 risk:0.87618073453599 found:1.76715365842585 highest:3.15344801954575 levels:2.14801295573182 60:1.47947158597407 men:3.44113009199753 measure:0.396607654274103 men:2.72337710063538 odds:0.984394319176222 advanced:3.84659520010569 ratios:0.654748047625409 relative:2.34251780332942 risk:1.22894829697494 selenium:3.84659520010569 toenails:4.02891675689965
274870 284230 developing:3.55891312765391 prostate:1.54401010711165 cancer:0.634408363388287 risk:0.87618073453599 risk:0.748005541111992 found:1.76715365842585 highest:3.15344801954575 levels:2.14801295573182 estimate:0.984394319176222 60:1.47947158597407 men:3.44113009199753 men:2.72337710063538 advanced:3.84659520010569 results:1.17244655067916 relative:4.68503560665884 line:0.634408363388287 risk:1.84342244546241 selenium:3.84659520010569 toenails:4.02891675689965 randomized:1.54401010711165
284230 296750 developing:3.55891312765391 prostate:1.54401010711165 trial:1.14971829960161 cancer:0.634408363388287 thinking:3.44113009199753 paper:2.11199414471758 risk:0.87618073453599 risk:0.748005541111992 lowest:1.07400647786591 estimate:0.984394319176222 60:1.47947158597407 men:3.44113009199753 compared:1.36168855031769 read:1.7263316639056 advanced:3.84659520010569 talk:0.520360856916991 results:1.17244655067916 chance:1.52748080516043 levels:2.34251780332942 line:0.634408363388287 lower:1.22894829697494 critiquing:0.296020417368935 detail:0.42341891172476 questions:1.83169217956343 toenails:4.02891675689965 randomized:1.54401010711165
296750 306230 authors:3.24045939653538 case:0.325148690291958 chance:1.14971829960161 cohort:2.32203570971108 conducted:2.54731221597543 control:0.919855798038651 critiquing:3.44113009199753 detail:2.11199414471758 cohort:2.69391569016731 nested:2.93030446823154 paper:1.7263316639056 questions:1.04072171383398 randomized:1.17244655067916 read:1.52748080516043 study:0.888061252106805 talk:0.42341891172476 thinking:1.83169217956343 trial:1.54401010711165
306230 318390 authors:3.24045939653538 case:0.325148690291958 cohort:2.32203570971108 conducted:2.54731221597543 control:0.919855798038651 critiquing:3.44113009199753 detail:2.11199414471758 cohort:2.69391569016731 nested:2.93030446823154 questions:1.56108257075097 study:0.888061252106805 talk:0.42341891172476 thinking:1.83169217956343
318390 330160 question:2.14184710786727 case:3.55891312765391 authors:3.24045939653538 address:0.550758334101362 prostate:1.54401010711165 case:0.650297380583916 cohort:2.32203570971108 bit:2.4603008389858 conducted:2.54731221597543 control:0.919855798038651 sampling:1.14971829960161 researchers:1.83169217956343 cohort:2.69391569016731 nested:2.93030446823154 complex:2.80514132527753 advanced:3.84659520010569 question:1.56108257075097 design:1.94947521521981 principles:0.614474148487469 set:0.668541369757745 risk:0.37566448042886 study:0.59204083473787
330160 337400 address:2.14184710786727 advanced:3.55891312765391 bit:0.550758334101362 cancer:1.54401010711165 case:0.650297380583916 complex:2.4603008389858 control:0.919855798038651 design:1.14971829960161 identified:1.83169217956343 population:0.514390689930487 principles:2.80514132527753 prostate:3.84659520010569 question:0.520360856916991 researchers:1.94947521521981 risk:1.22894829697494 sampling:1.33708273951549 set:0.37566448042886 source:2.54731221597543
337400 347000 advanced:7.11782625530782 cancer:3.0880202142233 case:0.650297380583916 control:0.919855798038651 definition:1.68711095075232 design:1.14971829960161 diagnosed:1.66806275578162 discuss:1.9747930232041 identified:1.83169217956343 participant:1.92478260262944 population:0.514390689930487 prostate:7.69319040021138 question:0.520360856916991 researchers:1.94947521521981 risk:1.22894829697494 sampled:1.33708273951549 set:0.37566448042886 source:2.54731221597543
347000 358580 advanced:3.55891312765391 cancer:3.0880202142233 definition:1.68711095075232 diagnosed:5.00418826734486 discuss:1.9747930232041 participant:3.84956520525888 prostate:7.69319040021138 question:1.04072171383398 risk:1.22894829697494 sampling:0.668541369757745 set:0.37566448042886
358580 367760 advanced:3.55891312765391 cancer:3.0880202142233 set:0.919855798038651 diagnosed:5.00418826734486 discuss:1.9747930232041 1993:2.86576594709396 control:0.153557735843091 participant:7.69913041051776 risk:1.47947158597407 prostate:7.69319040021138 question:1.04072171383398 exclude:0.614474148487469 participant:0.37566448042886
367760 377090 cancer:1.54401010711165 potential:1.8397115960773 diagnosed:3.33612551156324 question:5.73153189418792 participant:0.153557735843091 participants:5.77434780788832 exclude:0.582108863985438 set:2.95894317194814 prostate:3.84659520010569 1993:1.04072171383398 participant:0.614474148487469 risk:0.37566448042886
377090 386180 case:0.325148690291958 control:1.8397115960773 diagnosed:1.66806275578162 exclude:5.73153189418792 number:0.153557735843091 participant:3.84956520525888 person:0.582108863985438 potential:2.95894317194814 question:1.04072171383398 risk:0.614474148487469 set:0.37566448042886
386180 394540 case:0.325148690291958 control:0.919855798038651 diagnosed:1.66806275578162 exclude:2.86576594709396 selenium:1.29454924748006 relates:0.396607654274103 person:0.582108863985438 potential:1.47947158597407 question:1.56108257075097 question:1.28164584264415 measurement:3.84659520010569 exposure:0.296020417368935 study:0.209009040379305
394540 406140 categorize:2.59383223161032 complicated:2.59383223161032 exposure:3.88364774244018 measurement:0.396607654274103 oftentimes:9.8904149775476 question:1.04072171383398 relates:1.28164584264415 selenium:3.84659520010569 simply:2.59383223161032 study:0.296020417368935 things:0.209009040379305
406140 416420 case:0.325148690291958 categorize:2.59383223161032 complicated:2.59383223161032 continuous:1.49521994294221 divided:0.725699783597694 equal:0.462204936759917 exposure:2.58909849496012 groups:0.249282939517245 measure:0.396607654274103 oftentimes:9.8904149775476 question:0.520360856916991 quintiles:4.53974238066564 simply:2.59383223161032 study:0.296020417368935 things:0.209009040379305 yesno:4.25206030821386
416420 425640 case:0.325148690291958 complicated:2.59383223161032 continuous:1.49521994294221 divided:0.725699783597694 equal:0.462204936759917 exposure:2.58909849496012 groups:0.249282939517245 levels:1.07400647786591 measure:0.793215308548206 oftentimes:4.9452074887738 question:0.520360856916991 quintiles:4.53974238066564 reflect:1.49521994294221 selenium:7.69319040021138 study:0.296020417368935 window:2.38025813131226 yesno:4.25206030821386
425640 436160 years:1.70652903660942 divided:0.725699783597694 equal:0.462204936759917 exposure:1.29454924748006 study:0.778542264972074 groups:0.249282939517245 happened:0.60791674794131 recently:1.94947521521981 influence:1.52748080516043 levels:1.07400647786591 measurement:0.396607654274103 quintiles:4.53974238066564 reflect:3.07340531187221 reflect:2.99043988588442 selenium:7.69319040021138 study:0.59204083473787 window:2.38025813131226 20:0.485063074835967
436160 445830 years:1.70652903660942 limitations:2.64262239577975 measurement:1.29454924748006 study:0.778542264972074 happened:0.60791674794131 recently:1.94947521521981 influence:1.52748080516043 potential:1.66806275578162 measurement:0.793215308548206 findings:1.47947158597407 reflect:3.07340531187221 reflect:2.99043988588442 selenium:3.84659520010569 interpretation:0.296020417368935 20:0.485063074835967
445830 453870 biases:2.64262239577975 concepts:1.92478260262944 core:4.25206030821386 epidemiology:1.43366204994278 exposure:2.58909849496012 findings:0.778542264972074 influence:1.94947521521981 interpretation:1.52748080516043 limitations:1.66806275578162 measurement:0.793215308548206 potential:1.47947158597407 recently:3.07340531187221 reflect:1.49521994294221 relate:1.28164584264415 study:0.296020417368935
453870 461980 bias:3.9495860464082 biases:2.64262239577975 concepts:1.92478260262944 concerned:2.08300660784433 core:4.25206030821386 epidemiology:1.43366204994278 estimate:0.748005541111992 exposure:2.58909849496012 finally:1.21951406153715 influence:1.94947521521981 limitations:1.66806275578162 measurement:0.793215308548206 potential:1.47947158597407 relative:2.34251780332942 relate:1.28164584264415 risk:0.614474148487469
461980 471150 bias:5.9243790696123 concepts:1.92478260262944 concerned:2.08300660784433 core:4.25206030821386 epidemiology:1.43366204994278 estimate:0.748005541111992 exposure:1.29454924748006 finally:1.21951406153715 gonna:3.55891312765391 great:2.34251780332942 influence:3.89895043043962 measurement:0.396607654274103 potential:1.47947158597407 relative:2.34251780332942 relate:1.28164584264415 risk:0.614474148487469
471150 478990 bias:5.9243790696123 compare:0.634408363388287 concerned:2.08300660784433 contrast:3.3357695763397 estimate:0.748005541111992 finally:2.4390281230743 gonna:3.55891312765391 great:2.34251780332942 influence:3.89895043043962 potential:1.47947158597407 question:1.04072171383398 relative:2.34251780332942 relates:1.28164584264415 risk:0.614474148487469 study:0.296020417368935 subsequent:3.07340531187221 undertaken:4.53974238066564
478990 489410 secondary:1.14971829960161 bias:1.9747930232041 clark:3.84659520010569 compare:0.634408363388287 contrast:3.3357695763397 final:1.21951406153715 1996:1.76715365842585 larry:4.9452074887738 analysis:1.36168855031769 potential:1.47947158597407 published:2.38025813131226 question:1.04072171383398 randomized:2.34489310135832 relates:1.28164584264415 found:4.02891675689965 study:0.888061252106805 subsequent:3.07340531187221 undertaken:4.53974238066564
489410 500950 secondary:1.14971829960161 risk:1.54401010711165 clark:3.84659520010569 compare:1.26881672677657 contrast:3.3357695763397 final:1.21951406153715 1996:1.76715365842585 larry:4.9452074887738 selenium:1.47947158597407 analysis:2.72337710063538 men:2.5028604534046 lower:3.84659520010569 published:2.38025813131226 question:0.520360856916991 randomized:3.51733965203748 relates:1.28164584264415 60:0.614474148487469 found:4.02891675689965 randomized:3.84659520010569 study:0.888061252106805 subsequent:3.07340531187221 undertaken:4.53974238066564
500950 510390 secondary:1.14971829960161 studies:3.55891312765391 selenium:1.40424816473649 risk:1.54401010711165 clark:3.84659520010569 prostate:0.634408363388287 randomized:2.41947884446554 1996:1.76715365842585 larry:4.9452074887738 selenium:1.47947158597407 analysis:2.72337710063538 men:2.5028604534046 lower:3.84659520010569 published:2.38025813131226 randomized:3.51733965203748 60:0.614474148487469 found:4.02891675689965 randomized:7.69319040021138 study:1.18408166947574 biomarkers:4.02891675689965 study:4.53974238066564
510390 518559 association:1.11656609228471 biomarkers:3.55891312765391 blood:1.40424816473649 cancer:1.54401010711165 epidemiological:2.41947884446554 found:1.76715365842585 inverse:2.99929733971849 levels:1.07400647786591 placebo:2.5028604534046 prostate:3.84659520010569 randomized:1.17244655067916 risk:1.22894829697494 selenium:7.69319040021138 study:0.59204083473787 toenails:4.02891675689965 undertaken:4.53974238066564
518558 528770 advanced:3.55891312765391 ago:1.70652903660942 association:1.11656609228471 biomarkers:3.55891312765391 blood:1.40424816473649 cancer:4.63203032133495 found:1.76715365842585 institute:3.3357695763397 inverse:2.99929733971849 levels:1.07400647786591 national:2.4603008389858 prostate:7.69319040021138 risk:1.22894829697494 select:1.44869992730732 selenium:7.69319040021138 studies:0.59204083473787 toenails:4.02891675689965 trial:1.54401010711165 undertaken:4.53974238066564 undertook:4.53974238066564 years:0.485063074835967
528770 538130 advanced:3.55891312765391 ago:1.70652903660942 based:1.00362568110411 cancer:4.63203032133495 conducted:2.54731221597543 data:0.231182897873627 epidemiological:2.41947884446554 institute:3.3357695763397 national:2.4603008389858 prostate:11.5397856003171 risk:1.22894829697494 select:2.89739985461464 selenium:3.84659520010569 specifically:1.29454924748006 study:0.296020417368935 trail:4.9452074887738 trial:1.54401010711165 undertaken:4.53974238066564 undertook:4.53974238066564 years:0.485063074835967
538130 547130 agent:2.93030446823154 ago:1.70652903660942 based:1.00362568110411 cancer:4.63203032133495 chemo:4.9452074887738 conducted:2.54731221597543 data:0.231182897873627 epidemiological:2.41947884446554 institute:3.3357695763397 national:2.4603008389858 potential:1.47947158597407 preventive:5.18766446322064 primary:2.38025813131226 prostate:7.69319040021138 select:2.89739985461464 selenium:7.69319040021138 specifically:1.29454924748006 study:0.296020417368935 thinking:1.83169217956343 trail:4.9452074887738 trial:1.54401010711165 undertaken:4.53974238066564 undertook:4.53974238066564 years:0.485063074835967
547130 555620 agent:2.93030446823154 based:1.00362568110411 cancer:3.0880202142233 chemo:4.9452074887738 conducted:2.54731221597543 data:0.231182897873627 epidemiological:2.41947884446554 states:2.64262239577975 35000:1.36168855031769 potential:1.47947158597407 preventive:5.18766446322064 primary:2.38025813131226 prostate:7.69319040021138 recruited:3.07340531187221 select:1.44869992730732 selenium:7.69319040021138 specifically:1.29454924748006 united:1.41884696415764 thinking:1.83169217956343 trail:4.9452074887738 undertaken:4.53974238066564 men:1.70652903660942
555620 567450 agent:2.93030446823154 randomized:0.281768394661733 cancer:4.63203032133495 chemo:4.9452074887738 factorial:1.14971829960161 time:2.64262239577975 called:3.44113009199753 states:2.64262239577975 35000:1.36168855031769 vitamin:2.5028604534046 potential:1.47947158597407 preventive:5.18766446322064 primary:2.38025813131226 prostate:3.84659520010569 diagnosis:1.17244655067916 design:1.87715455364018 recruited:3.07340531187221 selenium:11.5397856003171 united:1.41884696415764 thinking:1.83169217956343 cancer:0.0700101655726489 men:1.70652903660942 selenium:5.99859467943698
567450 576560 average:2.1689555554664 called:0.281768394661733 cancer:1.54401010711165 design:1.14971829960161 diagnosis:2.64262239577975 factorial:3.44113009199753 follow:1.02323415249249 placebo:2.5028604534046 published:2.38025813131226 randomized:1.17244655067916 received:1.87715455364018 selenium:7.69319040021138 study:0.59204083473787 time:0.0700101655726489 vitamin:5.99859467943698 years:0.485063074835967
576560 587100 association:1.11656609228471 average:2.1689555554664 cancer:1.54401010711165 clark:3.84659520010569 contrast:3.3357695763397 epidemiological:2.41947884446554 follow:1.02323415249249 found:1.76715365842585 larry:4.9452074887738 placebo:2.5028604534046 prostate:3.84659520010569 published:2.38025813131226 randomization:1.17244655067916 received:1.87715455364018 results:0.634408363388287 risk:0.614474148487469 selenium:11.5397856003171 study:1.18408166947574 vitamin:5.99859467943698 years:0.485063074835967
587100 597810 association:1.11656609228471 cancer:1.54401010711165 clark:3.84659520010569 contrast:3.3357695763397 protective:0.96552583487184 epidemiological:2.41947884446554 found:1.87715455364018 found:3.5343073168517 larry:4.9452074887738 prostate:3.84659520010569 evidence:3.07340531187221 randomization:1.17244655067916 relative:2.34251780332942 results:0.634408363388287 risk:1.22894829697494 selenium:7.69319040021138 study:0.888061252106805 years:0.485063074835967
597810 605880 association:1.11656609228471 cancer:3.0880202142233 clark:3.84659520010569 protective:0.96552583487184 found:1.87715455364018 found:3.5343073168517 cancer:2.64262239577975 larry:4.9452074887738 supplementation:2.59383223161032 prostate:7.69319040021138 evidence:3.07340531187221 guess:0.520360856916991 randomization:1.17244655067916 relative:2.34251780332942 results:0.634408363388287 risk:1.22894829697494 selenium:7.69319040021138 study:0.296020417368935 selenium:3.69244452027843
605880 614110 question:2.02743675668952 prostate:1.54401010711165 question:0.634408363388287 randomized:0.919855798038651 advantages:2.99929733971849 protective:0.96552583487184 compared:2.41947884446554 found:1.87715455364018 104:1.76715365842585 cancer:2.64262239577975 supplementation:2.59383223161032 prevention:3.84659520010569 evidence:3.07340531187221 guess:1.04072171383398 disadvantages:1.17244655067916 relative:2.34251780332942 risk:0.614474148487469 effect:3.84659520010569 epidemiological:0.296020417368935 selenium:3.69244452027843 control:1.54401010711165
614110 623410 advantages:2.02743675668952 bias:1.9747930232041 cancer:1.54401010711165 compared:0.634408363388287 concerned:2.08300660784433 confounding:1.36168855031769 control:0.919855798038651 disadvantages:2.99929733971849 epidemiological:2.41947884446554 explanations:2.38025813131226 guess:2.64262239577975 plausible:3.44113009199753 prevention:2.59383223161032 prostate:3.84659520010569 question:1.04072171383398 randomized:1.17244655067916 study:0.296020417368935 supplementation:3.69244452027843 trial:1.54401010711165
623410 635200 advantages:2.02743675668952 bias:1.9747930232041 compared:0.634408363388287 comparison:1.9747930232041 concerned:2.08300660784433 confounding:1.36168855031769 control:1.8397115960773 critique:3.44113009199753 disadvantages:2.99929733971849 epidemiological:4.83895768893108 explanations:2.38025813131226 exposure:1.29454924748006 final:1.21951406153715 interpretation:1.52748080516043 outcomes:0.654748047625409 plausible:3.44113009199753 question:1.04072171383398 randomized:2.34489310135832 study:1.18408166947574 trial:1.54401010711165
635200 644760 answers:0.538488241509547 bias:1.9747930232041 comments:2.86576594709396 comparison:1.9747930232041 confounding:1.36168855031769 controlled:0.919855798038651 critique:6.88226018399506 epidemiological:2.41947884446554 exposure:1.29454924748006 final:1.21951406153715 forward:2.30615015915854 interpretation:1.52748080516043 logging:2.34251780332942 outcomes:0.654748047625409 post:2.86576594709396 providing:2.05483573087764 question:1.04072171383398 randomized:1.17244655067916 study:0.888061252106805 thoughts:1.92478260262944
644760 654100 answers:0.538488241509547 comments:2.86576594709396 critique:6.88226018399506 final:1.21951406153715 forward:2.30615015915854 letting:3.24045939653538 logging:2.34251780332942 part:1.0844777777332 post:2.86576594709396 providing:2.05483573087764 question:1.04072171383398 study:0.296020417368935 thoughts:1.92478260262944
